Latest News

Via The Motley Fool · May 30, 2025

Via The Motley Fool · May 30, 2025

It's a bold statement, but if he's right, the stock would generate life-changing investment returns.
Via The Motley Fool · May 30, 2025

The future of America's most prominent healthcare corporation has become increasingly uncertain.
Via The Motley Fool · May 30, 2025

Indian share markets are trading lower today, with the Sensex trading 101 points lower and the Nifty is trading 40 points lower.
Via Talk Markets · May 30, 2025

After VeChain bounced from a low of $0.0212 during major wave V, it surged to a recent high of $0.0315.
Via Talk Markets · May 30, 2025

X FINANCIAL-ADR (NYSE:XYF) shows strong earnings growth, profitability, and reasonable valuation, making it a candidate for GARP investors following Peter Lynch’s strategy.
Via Chartmill · May 30, 2025

Via The Motley Fool · May 30, 2025

Via The Motley Fool · May 30, 2025

Via The Motley Fool · May 30, 2025

Via The Motley Fool · May 30, 2025

GILEAD SCIENCES (NASDAQ:GILD) is a high-quality biopharma stock with strong profitability, efficient capital use, and attractive valuation, making it a candidate for long-term investors.
Via Chartmill · May 30, 2025

Via The Motley Fool · May 30, 2025

Via The Motley Fool · May 30, 2025

Via The Motley Fool · May 30, 2025

Earlier this week, AMC announced a record Memorial Day holiday weekend performance in terms of both admissions and food and beverage revenue.
Via Stocktwits · May 30, 2025

Via The Motley Fool · May 30, 2025

Not every investor should copy what Warren Buffett does.
Via The Motley Fool · May 30, 2025

Tepper's net-selling activity in AI stocks may have to do with more than just simple profit-taking.
Via The Motley Fool · May 30, 2025